A.M.M. Eggermont
Impact in
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 56
- Cutaneous Melanoma Detection and Management 35
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 6
-
- Melanoma and MAPK Pathways 12
- Co-authors
- Johannes H. W. de Wilt (8 shared papers)Timo L.M. ten Hagen (13 shared papers)Sandra T. van Tiel (7 shared papers)Albertus N. van Geel (9 shared papers)Stefan Suciu (17 shared papers)Johannes H.W. de Wilt (4 shared papers)D. Liénard (11 shared papers)Joost M. Klaase (7 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)British Journal of Cancer (10 papers)Melanoma Research (9 papers)European Journal of Cancer (7 papers)European Journal of Surgical Oncology (7 papers)
- Partner nations
- NetherlandsBelgiumGermany
In The Last Decade
A.M.M. Eggermont
94 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Oncology 1.2k
- Immunology 602
- Immunology and Allergy 101
- Pulmonary and Respiratory Medicine 482
- Rheumatology 168
Countries citing papers authored by A.M.M. Eggermont
This map shows the geographic impact of A.M.M. Eggermont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M.M. Eggermont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M.M. Eggermont more than expected).
Fields of papers citing papers by A.M.M. Eggermont
This network shows the impact of papers produced by A.M.M. Eggermont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M.M. Eggermont. The network helps show where A.M.M. Eggermont may publish in the future.
Co-authors
The 25 scholars most cited alongside A.M.M. Eggermont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 158 | |
| 2 | 2003 | 145 | |
| 3 | 2009 | 126 | |
| 4 | 2000 | 123 | |
| 5 | 2007 | 99 | |
| 6 | 1999 | 86 | |
| 7 | 1995 | 82 | |
| 8 | 1996 | 76 | |
| 9 | 2003 | 72 | |
| 10 | 2006 | 69 | |
| 11 | 2001 | 51 | |
| 12 | 1993 | 49 | |
| 13 | 2001 | 48 | |
| 14 | 2008 | 48 | |
| 15 | 1994 | 44 | |
| 16 | 2006 | 42 | |
| 17 | 2005 | 37 | |
| 18 | 2008 | 35 | |
| 19 | 2010 | 34 | |
| 20 | 2005 | 34 |
About A.M.M. Eggermont
A.M.M. Eggermont is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Surgery, having authored 94 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (35 papers), Immunotherapy and Immune Responses (17 papers), Sarcoma Diagnosis and Treatment (14 papers), Melanoma and MAPK Pathways (12 papers), Cell Adhesion Molecules Research (8 papers), Virus-based gene therapy research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (602 citations), Immunology and Allergy (101 citations), Pulmonary and Respiratory Medicine (482 citations) and Rheumatology (168 citations). A.M.M. Eggermont has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Johannes H. W. de Wilt, Timo L.M. ten Hagen, Sandra T. van Tiel, Albertus N. van Geel, Stefan Suciu, Johannes H.W. de Wilt, D. Liénard, Joost M. Klaase, Cornelis Verhoef and J.R. Marsden. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Melanoma Research, European Journal of Cancer and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.